SAP modulates B cell functions in a genetic background-dependent manner.

Immunol Lett

Division of Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Published: June 2013

AI Article Synopsis

  • Mutations in the SLAM-associated protein (SAP) lead to X-linked lympho-proliferative syndrome (XLP), a serious immune deficiency with effects like fatal mononucleosis and B cell lymphoma.
  • Despite the absence of SAP in B cells, research shows that B cell responses are compromised in SAP-deficient mice, influenced by the genetic background affecting B cell maintenance.
  • Interestingly, stimulation with anti-CD40 can enhance B cell responses in SAP-deficient mice, highlighting potential treatment avenues for some XLP patients.

Article Abstract

Mutations affecting the SLAM-associated protein (SAP) are responsible for the X-linked lympho-proliferative syndrome (XLP), a severe primary immunodeficiency syndrome with disease manifestations that include fatal mononucleosis, B cell lymphoma and dysgammaglobulinemia. It is well accepted that insufficient help by SAP-/- CD4+ T cells, in particular during the germinal center reaction, is a component of dysgammaglobulinemia in XLP patients and SAP-/- animals. It is however not well understood whether in XLP patients and SAP-/- mice B cell functions are affected, even though B cells themselves do not express SAP. Here we report that B cell intrinsic responses to haptenated protein antigens are impaired in SAP-/- mice and in Rag-/- mice into which B cells derived from SAP-/- mice together with wt CD4+ T cells had been transferred. This impaired B cells functions are in part depending on the genetic background of the SAP-/- mouse, which affects B cell homeostasis. Surprisingly, stimulation with an agonistic anti-CD40 causes strong in vivo and in vitro B cell responses in SAP-/- mice. Taken together, the data demonstrate that genetic factors play an important role in the SAP-related B cell functions. The finding that anti-CD40 can in part restore impaired B cell responses in SAP-/- mice, suggests potentially novel therapeutic interventions in subsets of XLP patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758805PMC
http://dx.doi.org/10.1016/j.imlet.2013.06.003DOI Listing

Publication Analysis

Top Keywords

sap-/- mice
20
cell functions
12
xlp patients
12
cell
8
sap-/-
8
cd4+ cells
8
patients sap-/-
8
cell responses
8
responses sap-/-
8
mice
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!